Valuation check: EXAI's profit margin is -881.8%, below the Healthcare sector average of 13.39%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2024
Trailing 12 months ending Sep 2024
The latest profit margin for EXAI is -881.8% as of September 2024. That compares with -587.75% in the prior-year period — down 50.0% year over year. That is below the Healthcare sector average of 13.39%. Investors often review this figure alongside Exscientia Plc's historical trend and sector peers before judging valuation or financial health.
Over the past year, EXAI's profit margin moved from -587.75% to -881.8% — a 50.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Exscientia Plc's valuation or profitability profile.
Against Healthcare companies, EXAI currently prints -881.8% for profit margin, while the sector average sits near 13.39%. That is roughly 6687.5% below the sector mean. Large gaps often invite a closer look at Exscientia Plc's growth, margins, and balance sheet.
Profit Margin shows how effectively Exscientia Plc converts resources into returns. At -881.8%, EXAI may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -587.75% in the prior-year period — down 50.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting EXAI's profit margin (-881.8%), review year-over-year change from -587.75%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.